King C. Lee, Ph.D.,Vice President, Regulatory and Clinical Affairs
Dr. Lee was most recently the Vice President of Regulatory Affairs for Acorda Therapeutics. Prior to Acorda Therapeutics Dr. Lee was Executive Director of Regulatory Affairs/Quality Assurance with ATON Pharmaceuticals (purchased by Merck in 2003). Previously, Dr. Lee was the Director of Regulatory Affairs/Quality Assurance for VION Pharmaceuticals from 1996 through 2001, and was the Manager of Regulatory Affairs/Clinical Affairs for IBEX Technologies from 1993 to 1996.
Dr. Lee has authored and co-authored over 40 publications (scientific and professional papers, books and review articles) and numerous scientific abstracts. He received his Ph.D. in Pharmacology from the University of Kentucky in 1983 and was certified by the Regulatory Affairs Professionals Board in 1994.
